Nivagen Pharmaceuticals
Call now
Call now
Website
Call
Nivagen's business model is to identify and utilize the world's best and economical CROs and CRAMs to develop and manufacture niche generic and OTC products. The US generic market is large and growing. The market is complex and fragmented and requires a variety of infrastructures to reach all major channels and segments.

Every business has its individual core strengths. One of Nivagen's core strengths is the ability of our sales team to launch new generic products in the US market. Nivagen is engaged in the development, acquisition and sales of generic prescription drugs and over the counter products for the North American market.
Services
Nivagen develops all products using a Quality by Design (QbD) approach. Since the quality of our products depends on the quality of our services, you can rest assured knowing that your project is in the hands of a team of passionate experts who are ready to bring your project to life. Contact us today to discuss how we can work together to help you achieve your goals.
The US generic market is large and growing. The market is complex and fragmented, requiring a variety of infrastructures to reach all major channels and segments. This is usually a difficult process for all except the few big pharmaceutical players.

Nivagen has exceptional market access and is looking to in-license products from pharmaceutical companies whose products are either already FDA approved, or are in the developmental stage and in need of Nivagen's expertise to launch into the US market.If you have formulations ready, Nivagen can provide market research on potential market size and the competitive environment.
To this end, Nivagen is actively looking for development and co-development partners. Beginning in the lab, to the logistics team, to the contract and finance experts. The pharmaceutical industry is highly research and innovation intensive. Nivagen partners with specialized and industry-leading research labs around the world to co-develop branded and complex generic products on a shared risk and profit basis.
Having launched more than 11 products under the Nivagen label in the last two years, one of Nivagen's core strengths is the ability of our sales team to quickly launch products in the US market. The Nivagen sales team has decades of experience in launching prescription drug products in the US's highly regulated markets.
As a registered pharmacist with an MBA in pharmaceutical management, and over 20 years of diverse experience both in Asia and the USA, Jay brings expertise from both sides of the world. He specializes in business development, corporate strategy, sourcing and international business.

Jay acquired more than 4 years of Indian pharmaceutical industry experience where he worked at different levels of supply chains: starting as a sales representative, and going up to product manager, and everything in between.
Reviews
Review Nivagen Pharmaceuticals

Be the first to review Nivagen Pharmaceuticals.

Write a Review